logo
‘Take us seriously': QLD nurses and midwives to ramp up industrial action next week over pay dispute with Queensland Health

‘Take us seriously': QLD nurses and midwives to ramp up industrial action next week over pay dispute with Queensland Health

Sky News AU3 days ago
Queensland nurses will increase their industrial action from next week after demands including wage increases were not met by Queensland Health.
The Queensland Nurses and Midwives Union (QNMU) is calling for a 13% wage increase over two and a half years, as well as increased support and expansion of the rural and remote workforce.
QNMU secretary Sarah Beaman said the union has spent more than 150 hours negotiating with Queensland Health, and they were left with no choice but to ramp up industrial action.
'Our members are furious after the repeated delays that have led us to this point,' she said.
'The only way we can make the government take us seriously is by taking stronger Protected Industrial Action.'
The statewide action will include activities such as no overtime unless there has been a minimum of four hours' notice, no answering administrative phones, and no entering of Medicare details at patient admissions, along with a list of other actions.
Ms Beaman has called on the government to 'break the stalemate' and meet the union's demands.
'Nurses and midwives are holding the system together through sheer heart, skill and relentless effort – without us, it doesn't function,' she said.
'The government can break the stalemate at any time by bringing a genuine offer and response to the QNMU's pay and conditions claim.'
'If we do nothing, there simply will not be enough nurses and midwives to safely staff our expanding hospital and care for you and your loved ones.'
The union they believed they had found 'some common ground' with Queensland Health, until it all 'fell apart' last week.
'On the final day of talks, Queensland Health pulled the rug out from under us, declaring that everything we thought was agreed was suddenly off the table,' they said.
'This is blatant gaslighting – and we won't stand for it.'
The union confirmed industrial action would begin on Tuesday, July 8 from 7 am.
QNMU had been taking 'Stage 1' industrial action since June 5, which included wearing pink, showing stickers, and sharing EB12 materials, including resources and posters.
The union has also made an application to the Queensland Industrial Relations Commission regarding the negotiations, and confirmed industrial action will not 'compromise patient safety' or the safety of other persons.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Protoemics diabetes test gets important US health insurance nod
Protoemics diabetes test gets important US health insurance nod

The Age

time2 days ago

  • The Age

Protoemics diabetes test gets important US health insurance nod

Proteomics International is on the verge of releasing its groundbreaking PromarkerD diabetes-related blood test across the United States, a milestone step ahead the device's international commercialisation. PromarkerD has just been assigned an American Medical Association PLA billing code, required for doctors to order the test and for facilities to bill for its use. From October 1, patients and healthcare providers will be able to submit claims for the test to be reimbursed by their health insurers – an essential step towards a broader market uptake. PromarkerD was designed to meet an area of unmet need by identifying diabetic patients at risk of developing kidney disease four years before any symptoms appear. According to the company's latest clinical study, its patented next-generation PromarkerD test accurately predicted kidney function decline in up to 86 per cent of patients who otherwise showed no symptoms, replicating the results from earlier clinical trials. 'Ensuring kidney health is a priority for our company and obtaining this dedicated PLA code is a crucial milestone in our strategy to improve access to meaningful diagnostic tests.' Proteomics International managing director Dr Richard Lipscombe Catching early signs of diabetic kidney disease means patients can receive preventive care well before they develop costly and life-threatening end-stage kidney disease, avoiding the need for dialysis or a kidney transplant. The simple finger-prick blood test could potentially throw a lifeline to more than 32 million Americans living with type 2 diabetes, given more than half of all adults with diabetes in the US will develop kidney complications. These cases contribute to a colossal US$130 billion in annual healthcare costs - more than a quarter of the nation's Medicare budget. Proteomics International managing director Dr Richard Lipscombe said: 'Ensuring kidney health is a priority for our company and obtaining this dedicated PLA code is a crucial milestone in our strategy to improve access to meaningful diagnostic tests. Expanding access to PromarkerD will help to improve kidney health for patients everywhere.' The PLA code is widely used across America's complex health insurance system to report the use of medical procedures and services. It also allows insurers to monitor their use.

Protoemics diabetes test gets important US health insurance nod
Protoemics diabetes test gets important US health insurance nod

Sydney Morning Herald

time2 days ago

  • Sydney Morning Herald

Protoemics diabetes test gets important US health insurance nod

Proteomics International is on the verge of releasing its groundbreaking PromarkerD diabetes-related blood test across the United States, a milestone step ahead the device's international commercialisation. PromarkerD has just been assigned an American Medical Association PLA billing code, required for doctors to order the test and for facilities to bill for its use. From October 1, patients and healthcare providers will be able to submit claims for the test to be reimbursed by their health insurers – an essential step towards a broader market uptake. PromarkerD was designed to meet an area of unmet need by identifying diabetic patients at risk of developing kidney disease four years before any symptoms appear. According to the company's latest clinical study, its patented next-generation PromarkerD test accurately predicted kidney function decline in up to 86 per cent of patients who otherwise showed no symptoms, replicating the results from earlier clinical trials. 'Ensuring kidney health is a priority for our company and obtaining this dedicated PLA code is a crucial milestone in our strategy to improve access to meaningful diagnostic tests.' Proteomics International managing director Dr Richard Lipscombe Catching early signs of diabetic kidney disease means patients can receive preventive care well before they develop costly and life-threatening end-stage kidney disease, avoiding the need for dialysis or a kidney transplant. The simple finger-prick blood test could potentially throw a lifeline to more than 32 million Americans living with type 2 diabetes, given more than half of all adults with diabetes in the US will develop kidney complications. These cases contribute to a colossal US$130 billion in annual healthcare costs - more than a quarter of the nation's Medicare budget. Proteomics International managing director Dr Richard Lipscombe said: 'Ensuring kidney health is a priority for our company and obtaining this dedicated PLA code is a crucial milestone in our strategy to improve access to meaningful diagnostic tests. Expanding access to PromarkerD will help to improve kidney health for patients everywhere.' The PLA code is widely used across America's complex health insurance system to report the use of medical procedures and services. It also allows insurers to monitor their use.

Nurses reject Crisafulli's claim wage offer is ‘nation leading'
Nurses reject Crisafulli's claim wage offer is ‘nation leading'

Sydney Morning Herald

time2 days ago

  • Sydney Morning Herald

Nurses reject Crisafulli's claim wage offer is ‘nation leading'

Premier David Crisafulli insists the industrial offer to nurses and midwives sets out 'nation-leading wages', but the union accused the government of gaslighting workers and has confirmed stronger protected action will kick off on Tuesday. The premier said nurses and midwives employed by Queensland Health had been offered nation-leading pay conditions and that the budget, handed down last week, reflects the government's commitment to the sector and is in line with a key election promise. 'We are determined to make sure that we deliver what we said we're going to do [before the election], and that is making sure those nurses do have nation-leading pay conditions,' Crisafulli said. 'We will continue to sit down at the table and do it in a spirit that shows that we respect what they do.' The state government revealed its public sector wages offer earlier this year, with 3 per cent in April 2025, 2.5 per cent in April 2026 and 2027, and an extra 3 per cent in December 2027. Loading But the Queensland Nurses and Midwives' Union (QNMU) said 66.7 per cent of nurses and midwives would be paid less than their Victorian counterparts by the end of the agreement and demanded the offer be increased. The union also called for measures to address gender pay equity and workforce shortages. Though the QNMU has met with the state government 36 times in the last six months, an agreement between the parties has not been reached.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store